Search

Search Constraints

You searched for: Author/Creator Chou, Takaaki

Search Results

1. A case of endocapillary proliferative glomerulonephritis with macrophages phagocytosing monoclonal immunoglobulin lambda light chain. (19th November 2014)

2. A multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trial. Issue 1 (December 2015)

3. A multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trial. Issue 1 (December 2015)

4. A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma. (5th January 2016)

5. A prospective analysis of clinical efficacy and safety in chronic myeloid leukemia‐chronic phase patients with imatinib resistance or intolerance as evaluated using European LeukemiaNet 2013 criteria. (25th March 2015)

6. Carfilzomib monotherapy in Japanese patients with relapsed or refractory multiple myeloma: A phase 1/2 study. Issue 9 (10th August 2019)

7. Carfilzomib, lenalidomide and dexamethasone in patients with heavily pretreated multiple myeloma: A phase 1 study in Japan. Issue 3 (3rd April 2017)

8. Carfilzomib, lenalidomide and dexamethasone in patients with heavily pretreated multiple myeloma: A phase 1 study in Japan. Issue 3 (March 2017)

9. Clinical profiles of multiple myeloma in Asia—An Asian Myeloma Network study. Issue 7 (26th April 2014)

10. Efficacy and safety of weekly carfilzomib (70 mg/m2), dexamethasone, and daratumumab (KdD70) is comparable to twice-weekly KdD56 while being a more convenient dosing option: a cross-study comparison of the CANDOR and EQUULEUS studies. Issue 2 (28th January 2021)